Randomized double-blind comparison of chimeric monoclonal antibody to tumor necrosis factor alpha (infliximab) versus placebo in active spondylarthropathy.
Arthritis Rheum. 2002 Mar;46(3):755-65. doi: 10.1002/art.511.
Arthritis Rheum. 2002.
PMID: 11920412
Clinical Trial.